NMD Pharma A/S | LinkedIn
Company Presentation
NMD Pharma
NMD | LinkedIn
NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma Receives Approval to Start a combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
Big deal: NMD flexes series A muscles - Global University Venturing
Prominent Canadian researcher in Denmark: Why I left a top job in California
Klaus Wilhardt - Corporate identity, Design, Logo/navnetræk og designguides
NMD Pharma company information, funding & investors | Dealroom.co
Roel Bulthuis - Director at NMD Pharma | The Org
Erhverv Aarhus - 照片| Facebook
NMD Pharma Information | NMD Pharma Profile
NMD Pharma - Inkef capital
Labiotech.eu on Twitter: "NMD Pharma, from @AarhusUni, is willing to tackle Neuromuscular Transmission Disorders #BioEquity2016… "
Detailed Description | NMD-GPS
NMD Pharma | The Org
Nete Huus's email & phone | NMD Pharma ApS's Senior Scientist email
Management — NMD Pharma
NMD Pharma raises €38M (~USD 47 Million) SERIES A Financing to Advance Treatments of Neuromuscular Disorders
NMD Pharma - PIR International
Investors — NMD Pharma
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
